Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients

UnknownOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

September 30, 2021

Study Completion Date

January 31, 2022

Conditions
Fabry Disease
Interventions
GENETIC

GLA gene

Genetic test will be performed when enzyme activity is found abnormal in the whole blood test or confirmation is required. 5 ml of blood sample will be obtained and polymerase chain reaction (PCR) sequencing will be executed to determine mutations in the GLA gene.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Chiayi Christian Hospital

OTHER